At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 65 enrolled
Drug / intervention
Bupropion SR +2 moredrug
Likely dose
Bupropion SR 150 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bupropion for Smoking Cessation During Pregnancy
The University of Texas Medical Branch, Galveston·interventional·Posted Jul 8, 2011·Updated Jun 7, 2019
In Brief
A Phase 4 clinical trial evaluating Bupropion SR, Smoking Cessation Counseling, and 1 other intervention for Pregnancy Related and Tobacco Use Disorder. Completed, enrolled 65 participants across 1 site.
Detailed Summary
This is a prospective, double-blind placebo-controlled randomized pilot trial of the preliminary safety and efficacy of bupropion SR in combination with behavioral counseling for smoking cessation during pregnancy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy Related, Tobacco Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA), UConn Health
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2011
Primary CompletionDec 2016
TodayJul 2026
First PostedJul 8, 2011
Enrollment StartJul 1, 2011
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 15.0 years ago
Interventions
Bupropion SRdrug
Bupropion SR 150 mg tablet
Smoking Cessation Counselingbehavioral
35-min counseling by trained research nurse
Placebodrug
Matching Bupropion SR placebo tablet